A randomized trial of photoselective vaporization of the prostate using the 80‐W potassium‐titanyl‐phosphate laser vs transurethral prostatectomy, with a 1‐year follow‐up
- 4 March 2010
- journal article
- research article
- Published by Wiley in BJU International
- Vol. 105 (7) , 964-969
Abstract
Study Type – Therapy (RCT) Level of Evidence 2b OBJECTIVE: To compare the potassium‐titanyl‐phosphate Greenlight TM 80‐W laser ablation system for photovaporization of the prostate (PVP; Laserscope, San Jose, CA, USA) with transurethral resection of the prostate (TURP), as many technologies have been proposed as equivalent or superior to TURP without gaining widespread acceptance, due to lack of data from randomized trials. PATIENTS AND METHODS: In all, 120 patients were randomized to undergo either TURP or PVP after a full urological evaluation, which was repeated at 1, 3, 6 and 12 months after surgery. Irrigation use, duration of catheterization (DOC), length of hospital stay (LOS), blood loss, cost and operative time were also assessed. RESULTS: Both groups showed a significant increase in mean ( sd ) maximum urinary flow rate from baseline ( P < 0.05); in the TURP group from 8.9 (3.0) to 19.4 (8.7) mL/s (154%), and in the PVP group from 8.8 (2.5) to 18.6 (8.2) mL/s (136%). The International Prostate Symptom Score (IPSS) decreased from 25.4 (5.7) to 10.9 (9.4) in the TURP group (53%), and from 25.3 (5.9) to 8.9 (7.6) in the PVP group (61%). The trends were similar for the bother and Quality of Life scores. There was no difference in sexual function as measured by Baseline Sexual Function Questionnaires. The DOC was significantly less in the PVP than the TURP group ( P < 0.001), with a mean (range) of 13 (0–24) h vs 44.7 (6–192) h. The situation was similar for LOS ( P < 0.001), with a mean (range) of 1.09 (1–2) and 3.6 (3–9) days in the PVP and TURP groups, respectively. Adverse events and complications were less frequent in the PVP group. Costs were also 22% less in the PVP group. CONCLUSIONS: This trial shows that PVP is an effective technique when compared to TURP, producing equivalent improvements in flow rates and IPSS with the advantages of markedly reduced LOS, DOC and adverse events. A long‐term follow‐up is being undertaken to ensure durability of these results.Keywords
This publication has 13 references indexed in Scilit:
- Comparison of potassium‐titanyl‐phosphate laser vaporization of the prostate and transurethral resection of the prostate: update of a prospective non‐randomized two‐centre studyBJU International, 2008
- Minimally invasive treatments for benign prostatic enlargement: systematic review of randomised controlled trialsBMJ, 2008
- Photoselective vaporization of the prostate with the potassium‐titanyl‐phosphate laser in men with prostates of >100 mLBJU International, 2007
- A Randomised Trial Comparing Holmium Laser Enucleation Versus Transurethral Resection in the Treatment of Prostates Larger Than 40Grams: Results at 2 YearsEuropean Urology, 2006
- The evolution of photoselective vaporization prostatectomy (PVP): advancing the surgical treatment of benign prostatic hyperplasiaWorld Journal of Urology, 2006
- Impact of prostate‐specific antigen level and prostate volume as predictors of efficacy in photoselective vaporization prostatectomy: analysis and results of an ongoing prospective multicentre study at 3 yearsBJU International, 2006
- Photoselective Laser Vaporization Prostatectomy in Men Receiving AnticoagulantsJournal of Endourology, 2005
- High-power potassium-titanyl-phosphate photoselective laser vaporization of prostate for treatment of benign prostatic hyperplasia in men with large prostatesUrology, 2004
- Photoselective Vaporization of the Prostate: Initial Experience with a New 80 W KTP Laser for the Treatment of Benign Prostatic HyperplasiaJournal of Endourology, 2003
- A Comparison of Transurethral Surgery with Watchful Waiting for Moderate Symptoms of Benign Prostatic HyperplasiaNew England Journal of Medicine, 1995